Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia

Expert Opinion on Investigational Drugs 2026

View at publisher
Authors: Akhil Rajendra, Karen W L Yee
DOI: 10.1080/13543784.2026.2656430
Cited by: 1
References: 13

Abstract

1. Although outcomes of patients with acute myeloid leukemia (AML) have improved in the last decade with the approval of venetoclax (VEN) and hypomethylating agents (HMA) and a number of targeted a...

Fields of Study & Subjects

Advanced Breast Cancer Therapies Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Expert Opinion on Investigational Drugs
Publisher
Informa UK Limited
Volume
35
Issue
4
Pages
253–256
Publication date
3 April 2026
Language
EN